Breast cancer stem cells: treatment resistance and therapeutic opportunities

Area of Science:

• Oncology
• Molecular Biology
• Cancer Stem Cell Research

Background:

• Human breast cancer exhibits significant clinical and pathological heterogeneity.
• Molecular profiling has enhanced understanding of breast cancer heterogeneity, providing new prognostic and predictive insights.
• Despite advances like trastuzumab, disease recurrence persists due to treatment-resistant cells.

Purpose of the Study:

• To explore the role of breast cancer stem-like cells in disease recurrence.
• To investigate the relationship between stem-like cells and treatment-resistant populations.
• To identify strategies for targeting treatment-resistant cells to improve breast cancer cure rates.

Main Methods:

• Review of current literature on breast cancer heterogeneity and stem cell models.
• Analysis of molecular profiling data in relation to treatment resistance.
• Exploration of therapeutic strategies targeting cancer stem-like cells and radioresistance.

Main Results:

• Breast cancer recurrence stems from residual treatment-resistant cells that can regenerate the initial cancer phenotype.
• The cancer stem cell model, contrasting with clonal evolution, offers insights into tumor development and resistance.
• Aberrant signaling pathways in treatment-resistant cells are potential therapeutic targets.

Conclusions:

• Targeting breast cancer stem-like cells and their associated signaling pathways is crucial for overcoming treatment resistance.
• Developing strategies to specifically target the treatment-resistant cell population, including radioresistant cells, is essential for increasing breast cancer cure rates.